Main protease mutants of SARS-CoV-2 variants remain susceptible to nirmatrelvir
Sven Ullrich, Kasuni B. Ekanayake, Gottfried Otting, Christoph Nitsche
Topics & Concepts
ChemistryProteaseMutantSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Virology2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)EnzymeBiochemistryGeneBiologyInfectious disease (medical specialty)MedicinePathologyDiseaseOutbreakSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesViral Infections and Immunology Research